Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
Abstract Neurodegenerative diseases (NDDs) remain a global health challenge. Alzheimer's disease (AD) and Parkinson's disease (PD) are the main types of NDDs worldwide, and Mendelian Randomization (MR) analysis across multi-omics and the entire genome offers novel strategies for identifying potential drug targets. This study used MR and summary-based MR(SMR) analysis to explore the causal relationship between genes and NDDs. Colocalization analysis and machine learning further validated and reinforced the MR findings. The pharmacological activity of candidate drug targets was confirmed via molecular docking and Molecular dynamics. This study revealed 14 genes that were closely associated with both NDDs. Specifically, IQCE(AD), HDHD2(AD), COMMD10(AD), ALPP (AD), FXYD6 (AD), STK3 (PD), LHFPL2 (PD), and ENPP4 (PD) were identified as risk factors for NDDs (OR > 1), whereas HEXIM2 (AD), TSC22D4 (AD), CHRNB1 (PD), BAG4 (PD), SLC25A1 (PD), and IL15 (PD) were protective factors (OR
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.